MedTrace Logo

KRAS Mutation and Incidence of the Colorectal Carcinoma in Martinique Between 2007 and 2009

NCT01151007 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2016-09-23

No results posted yet for this study

Summary

* There is no data at present concerning the KRAS mutation in patients from Martinique with colorectal cancer. Despite the fact that the incidence of this disease continues to increase there is no recent data to confirm it. This study has a descriptive purpose, allowing a comparison of the population from Martinique to other populations.
* A study of incidence of colorectal cancer, overseen by the Association from Martinique for the Epidemiological Search on Cancer (AMREC), also leads to a better knowledge of the local characteristics of the colorectal cancer.
* These two descriptive characteristics of colorectal cancer in Martinique will be useful data for the health professionals to provide their patients better care.

Conditions

  • Colorectal Carcinoma

Sponsors & Collaborators

  • University Hospital Center of Martinique

    lead OTHER

Principal Investigators

  • Odile BERA, MD · Laboratoire de virologie - Centre Hospitalier Universitaire de Fort de France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-10-31
Completion
2011-12-31

Countries

  • France

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01151007 on ClinicalTrials.gov